{"podcast":{"title":"Business Of Biotech","slug":"business-of-biotech-123501","podcast_index_feed_id":123501,"rss_url":"https://rss.buzzsprout.com/1011661.rss","website_url":"https://www.bioprocessonline.com/solution/the-business-of-biotech-podcast","image_url":"https://storage.buzzsprout.com/35u0bccu9j9xpr9zrrjias54otax?.jpg","author":"Ben Comer","episode_count":310,"summary":"The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.","last_synced_at":"2026-06-08T22:18:30.179389+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501"},"episode":{"title":"Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.","slug":"biotech-collaboration-strategy-with-igi-s-cyril-konto-m-d","published_at":"2025-11-24T11:00:00+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501/biotech-collaboration-strategy-with-igi-s-cyril-konto-m-d","show_page_url":"https://stenobird.com/podcast/business-of-biotech-123501","url":"https://www.buzzsprout.com/1011661/episodes/18217716-biotech-collaboration-strategy-with-igi-s-cyril-konto-m-d.mp3","audio_url":"https://www.buzzsprout.com/1011661/episodes/18217716-biotech-collaboration-strategy-with-igi-s-cyril-konto-m-d.mp3","summary":"We love to hear from our listeners. Send us a message. On this week's episode, Cyril Konto, M.D., president, executive director, and CEO at Ichnos Glenmark Innovation (IGI) talks about the promise of multi-specific antibodies, funding the company during the 'biotech winter,' closing a $700 million upfront licensing deal with AbbVie, the impact of China's rising biotech sector, and the keys to successful collaboration. Cyril also discusses IGI's focus on developing innovative therapies for em...","meta_description":"We love to hear from our listeners. Send us a message. On this week's episode, Cyril Konto, M.D., president, executive director, and CEO at Ichnos Glenmar…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3521,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/biotech-collaboration-strategy-with-igi-s-cyril-konto-m-d/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-of-biotech-123501/biotech-collaboration-strategy-with-igi-s-cyril-konto-m-d.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}